Implementing patient-reported outcomes in routine clinical care for diverse and underrepresented patients in the United States CJ Hyland, R Guo, R Dhawan, MN Kaur, PA Bain, MO Edelen, AL Pusic Journal of Patient-Reported Outcomes 6 (1), 20, 2022 | 23 | 2022 |
Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma MK Abel, H Greenwood, T Kelil, R Guo, C Brabham, N Hylton, J Wong, ... NPJ breast cancer 7 (1), 25, 2021 | 15 | 2021 |
Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater MK Abel, CE Brabham, R Guo, K Fahrner-Scott, J Wong, M Alvarado, ... The American Journal of Surgery 221 (1), 32-36, 2021 | 10 | 2021 |
Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast. R Guo, CE Brabham, K Fahrner-Scott, MK Abel, J Wong, M Alvarado, ... Journal of Clinical Oncology 38 (15_suppl), e12604-e12604, 2020 | 6 | 2020 |
Cardiac Myosin Inhibitors for Managing Obstructive Hypertrophic Cardiomyopathy: JACC: Heart Failure State-of-the-Art Review JW Ostrominski, R Guo, PM Elliott, CY Ho Heart Failure 11 (7), 735-748, 2023 | 4 | 2023 |
Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast: Factors associated with false negatives. RA Mukhtar, CE Brabham, R Guo, MK Abel, J Wong, C Ewing, ... Breast Journal 27 (4), 2021 | 4 | 2021 |
Adult and neonatal models of chemogenetic heart failure caused by oxidative stress F Spyropoulos, AA Das, M Waldeck-Weiermair, S Yadav, AK Pandey, ... The Journal of Clinical Investigation 134 (9), 2024 | 1 | 2024 |
An essential role for EROS in redox-dependent endothelial signal transduction M Waldeck-Weiermair, AA Das, TA Covington, S Yadav, J Kaynert, R Guo, ... Redox Biology, 103214, 2024 | | 2024 |
FRBM Mini REVIEW: Chemogenetic approaches to probe redox dysregulation in heart failure R Guo, F Spyropoulos, T Michel Free Radical Biology and Medicine, 2024 | | 2024 |
18F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant Chemotherapy D Diwanji, N Onishi, DK Hathi, C Lawhn-Heath, J Kornak, W Li, R Guo, ... Radiology: Imaging Cancer 6 (2), e230082, 2024 | | 2024 |
A high-touch outreach model to re-engage patients in mammogram screening. A Ojo, S Johnson, P Erfani, R Guo, A Garmilla, A Saini, B Benitez, ... Journal of Clinical Oncology 40 (16_suppl), e18555-e18555, 2022 | | 2022 |
RE-ENGAGING PATIENTS IN BREAST CANCER SCREENING THROUGH A SCALABLE, HIGH-TOUCH CARE MODEL S Johnson, A Ojo, P Erfani, R Guo, A Garmilla, A Saini, B Benitez, ... Journal of General Internal Medicine, S553-S553, 2022 | | 2022 |
Abstract PS13-50: Relationship of dedicated breast PET and MRI features in breast cancer patients receiving neoadjuvant chemotherapy DK Hathi, EF Jones, W Li, DC Newitt, R Guo, Y Seo, RR Flavell, BN Joe, ... Cancer Research 81 (4_Supplement), PS13-50-PS13-50, 2021 | | 2021 |
Predictors of Nodal Response after Neoadjuvant Therapy in Invasive Lobular Carcinoma of the Breast MK Abel, H Greenwood, T Kelil, C Brabham, R Guo, K Fahrner-Scott, ... ANNALS OF SURGICAL ONCOLOGY 27 (SUPPL 2), S543-S544, 2020 | | 2020 |
Abstract: Evaluating the Safety of Breast-conserving Therapy versus Mastectomy for Patients with Large Invasive Lobular Carcinoma of the Breast C Brabham, R Guo, K Fahrner-Scott, MK Abel, JW Wong, M Alvarado, ... The American Society of Breast Surgeons Official Proceedings, Volume XXI …, 2020 | | 2020 |
Overstepping Boundaries: Hotspot Mutation in GATA3 Promotes EMT and Metastasis in Breast Cancer R Guo | | 2019 |